Tuberculosis Molecular Diagnostics — iFIND TBR + IFQ
Workflow for detecting M. tuberculosis and drug-resistance markers relevant to the Indian context.
Manufacturer-provided information All technical parameters are manufacturer-provided (iFIND). Local CDSCO registration status is not verified.
Molecular Workflow & Cartridge Architecture
iFIND TBR + IFQ Molecular Workflow
-
1 SpecimenSample Collection & Lysis Sputum or alternative respiratory specimen. Automated or manual lysis per protocol.
-
2 Cartridge 1iFIND TBR (Primary Screen) Detection of M. tuberculosis complex DNA and rifampicin-resistance markers.IS6110 IS1081 / IS1087 rpoB
-
3 Cartridge 2iFIND IFQ (MDR Profiling) Expanded resistance detection for isoniazid and fluoroquinolones.katG inhA gyrA
-
4 ReportClinical Interpretation Integrated fluorescent quantification evaluated together with clinical context.
Evidence Boundary Note:
All parameters are manufacturer-provided (iFIND). IS1081/IS1087 target conflict and detection time discrepancy (85 min vs ≤120 min) are unresolved. Local regulatory status is not verified. This diagram is for educational purposes.
Manufacturer parameters
- Intended use
- Detection of M. tuberculosis complex DNA and resistance markers for rifampicin, isoniazid, fluoroquinolones and injectable agents. Manufacturer-provided information
- Specimen type
- Sputum or alternative respiratory specimen. Manufacturer-provided information
- Turnaround time
- Per manufacturer data. Manufacturer-provided information
- Room-temperature stability
- Manufacturer claim; verify for Indian logistics conditions. Manufacturer-provided information
India market status
Local regulatory status not verified Local CDSCO registration, import and service status are not verified.
- CDSCO registration
- Not checked
- Import status
- Not checked
- Laboratory evaluation in India
- No data
- Local service in India
- Not checked
Documentation
Documents are not publicly available. Request access to receive a signed, time-limited link.